Kliniska studier för Lupus i Iowa
6 studier för Lupus söker deltagare vid platser i Iowa.
Städer i Iowa
Officiell studietext (engelska)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50319, Iowa City
RekryterarFas 3
Ålder 16 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT06617325A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Research Site, Iowa City
RekryterarFas 1
Ålder 18 till 70 · Alla kön · Uppdaterad 15 sep. 2026 · NCT06916806A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- University of Iowa, Iowa City
RekryterarFas 1
Ålder 18 till 74 · Alla kön · Uppdaterad 10 sep. 2026 · NCT07085104A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- University of Iowa, Iowa City
RekryterarFas 1
Ålder 18 till 70 · Alla kön · Uppdaterad 28 aug. 2026 · NCT06925542Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
- Univeristy of Iowa, Iowa City
Rekryterar
Ålder 18 till 100 · Alla kön · Uppdaterad 10 aug. 2026 · NCT07180537A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
- University of Iowa, Iowa City
RekryterarFas 1
Ålder 18 till 70 · Alla kön · Uppdaterad 5 juni 2026 · NCT06613360Från ClinicalTrials.gov, data hämtad 4 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.